Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITA: Switching to Anastrozole vs Tamoxifen in Breast Cancer
NCT00286117Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 1998
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by AstraZeneca. Started Mar 1998; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00286117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286117.